KURA ONCOLOGY, INC. Public Float
KURA ONCOLOGY, INC. (KURA) had Public Float of $496.10 million as of 2025-06-30, per its 10-K filed 2026-03-05.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-05
- 2025-06-30: Entity Public Float $496.10M.
- 2024-06-28: Entity Public Float $1.60B.
- 2023-06-30: Entity Public Float $776.50M.
- 2022-06-30: Entity Public Float $1.20B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $496.10M 10-K · filed 2026-03-05 |
| 2024-06-28 | $1.60B 10-K · filed 2025-02-28 |
| 2023-06-30 | $776.50M 10-K · filed 2024-02-27 |
| 2022-06-30 | $1.20B 10-K · filed 2023-02-23 |
| 2021-06-30 | $1.30B 10-K · filed 2022-02-24 |
| 2020-06-30 | $877.90M 10-K · filed 2021-02-24 |
| 2019-06-28 | $822.00M 10-K · filed 2020-02-25 |
| 2018-06-29 | $525.40M 10-K · filed 2019-03-05 |
| 2017-06-30 | $157.10M 10-K · filed 2018-03-12 |
| 2016-06-30 | $45.80M 10-K · filed 2017-03-14 |
| 2015-06-30 | $0.00 10-K · filed 2016-03-17 |
| 2014-12-31 | $0.00 10-K · filed 2015-02-27 |
| 2013-12-31 | $0.00 10-K · filed 2014-03-31 |
| 2012-12-31 | $0.00 10-K · filed 2013-03-28 |
| 2011-12-31 | $0.00 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |